|
AR038136A1
(es)
*
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
|
|
AR041089A1
(es)
*
|
2003-05-15 |
2005-05-04 |
Merck & Co Inc |
Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
|
|
CA2594280C
(en)
|
2004-12-27 |
2013-04-23 |
Anja Fecher |
2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
|
|
US20080139604A1
(en)
*
|
2005-02-17 |
2008-06-12 |
Shaun Fitzpatrick |
Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
|
|
CA2612723A1
(en)
|
2005-06-24 |
2007-01-04 |
Eli Lilly And Company |
Tetrahydrocarbazole derivatives useful as androgen receptor modulators
|
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
|
EP2397476A3
(en)
|
2005-07-22 |
2011-12-28 |
Shionogi & Co., Ltd. |
Indole derivative having PGD2 receptor antagonist activity
|
|
EP1932839A4
(en)
|
2005-09-06 |
2014-09-10 |
Shionogi & Co |
INDOLECARBOXYLATE ACID DERIVATIVE HAVING ANTAGONIST EFFECT OF THE PGD2 RECEPTOR
|
|
US20090069275A1
(en)
*
|
2006-02-17 |
2009-03-12 |
Rocca Jose G |
Low flush niacin formulation
|
|
ATE530523T1
(de)
|
2006-08-07 |
2011-11-15 |
Actelion Pharmaceuticals Ltd |
(3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate
|
|
WO2008039882A1
(en)
*
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
|
EP2114154B1
(en)
*
|
2007-02-08 |
2013-08-28 |
Merck Sharp & Dohme Corp. |
Method of treating atherosclerosis, dyslipidemias and related conditions
|
|
CL2008000684A1
(es)
|
2007-03-09 |
2008-08-01 |
Indigene Pharmaceuticals Inc |
Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
|
|
BRPI0907364A2
(pt)
|
2008-02-01 |
2015-07-14 |
Amira Pharmaceuticals Inc |
Antagonistas aminoalquilbifenil n,n-disubstituídos de receptores d2 de prostaglandina
|
|
WO2009099901A1
(en)
*
|
2008-02-01 |
2009-08-13 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
WO2009102893A2
(en)
*
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
|
|
JP2011513242A
(ja)
*
|
2008-02-25 |
2011-04-28 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体アンタゴニスト
|
|
US8426449B2
(en)
*
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
EP2119705A1
(en)
*
|
2008-05-14 |
2009-11-18 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. |
3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
|
|
EA019713B1
(ru)
|
2008-05-16 |
2014-05-30 |
Эли Лилли Энд Компани |
ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛЬНЫЕ МОДУЛЯТОРЫ РЕЦЕПТОРОВ АНДРОГЕНОВ
|
|
CN102083466A
(zh)
*
|
2008-05-20 |
2011-06-01 |
科莱尼斯医疗公司 |
用于组合疗法的烟酸和nsaid
|
|
US8071807B2
(en)
|
2008-07-03 |
2011-12-06 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
GB2463788B
(en)
*
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US20100173313A1
(en)
*
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
EP2461809A4
(en)
|
2009-07-31 |
2013-06-19 |
Panmira Pharmaceuticals Llc |
OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONSITES
|
|
US8815917B2
(en)
*
|
2009-08-05 |
2014-08-26 |
Panmira Pharmaceuticals, Llc |
DP2 antagonist and uses thereof
|
|
EP2521713A4
(en)
|
2010-01-06 |
2013-10-02 |
Panmira Pharmaceuticals Llc |
ANTAGONIST OF DP2 AND ITS USES
|
|
AR080703A1
(es)
*
|
2010-03-22 |
2012-05-02 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma.
|
|
DK2697223T3
(en)
|
2011-04-14 |
2016-09-05 |
Actelion Pharmaceuticals Ltd |
7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor
|
|
PE20161177A1
(es)
|
2014-03-17 |
2016-11-18 |
Actelion Pharmaceuticals Ltd |
Derivados del acido acetico azaindol y su uso como moduladores del receptor de prostaglandina d2
|
|
WO2015140701A1
(en)
|
2014-03-18 |
2015-09-24 |
Actelion Pharmaceuticals Ltd |
Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
|
|
CN106032383B
(zh)
*
|
2015-03-19 |
2019-08-13 |
中国科学院上海药物研究所 |
一类三环类似物、其制备方法和用途
|
|
KR20180053345A
(ko)
|
2015-09-15 |
2018-05-21 |
이도르시아 파마슈티컬스 리미티드 |
결정질 형태
|
|
CN112362781A
(zh)
*
|
2020-11-09 |
2021-02-12 |
河北诚信集团有限公司 |
一种甲基亚磺酸钠的含量测定方法
|